| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Polyclonal antibody stimulator (Cancer Advances) | G-17DT | Phase 2 Clinical | Aphton Corp | Diabetes Mellitus, Type 1; Stomach Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Jaundice | Details |